Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01597-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von A Facchin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Valganciclovir, the ganciclovir prodrug, is an antiviral agent used to prevent cytomegalovirus infection in renal transplant children. Therapeutic drug monitoring is still necessary to ensure optimal therapeutic area under the concentration-time curve from 0 to 24 h (AUC 0–24 ) of 40 to 60 μg·h/mL since valganciclovir presents a high pharmacokinetic variability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France.
- Service of Pharmacy, Centre Hospitalier Intercommunal Nord Ardennes, Charleville-Mézières, France.
- University Paris -Cité, Paris, France.
ORCID-Profile: A Facchin
Zitieren
APA
Facchin, A., Benyoub, N., Elie, V., Magreault, S., & Jacqz-Aigrain, E. (2023). Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01597-22
Vancouver
Facchin A, Benyoub N, Elie V, Magreault S, Jacqz-Aigrain E. Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01597-22
BibTeX
@article{Facchin2023,
author = {Facchin, A and Benyoub, N and Elie, V and Magreault, S and Jacqz-Aigrain, E},
title = {Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01597-22}
}
EUVIMED